Summary

Geneza Pharmaceuticals GP Tren Enanth 200 is presented in a 10-milliliter multidose vial, labeled to contain 200 milligrams of trenbolone enanthate per milliliter. As part of AnabolicLab’s commitment to harm reduction and transparency, this product was independently tested to verify its composition and quality. The samples were obtained from a European-based internet source between January 1, 2016, and March 15, 2016, and analyzed by SIMEC AG, an internationally accredited laboratory.

The analysis revealed that the product contained 229.3 mg/ml trenbolone enanthate, exceeding the label claim by 14.7%. While this overdosage indicates significant deviation from the labeled specification, the product was verified as authentic using the manufacturer’s ISN number.

Testing Results and Authentication

The samples were received by SIMEC AG on April 1, 2016, and the report was finalized on April 14, 2016. The product was identified with the following details:

• Lot Number: GP147H
• Expiration Date: September 2018
• ISN Number: U7E3425A3353 (verified on genezapharmaceuticals.com)

Product Overview

• Manufacturer: Geneza Pharmaceuticals
• Product Name: GP Tren Enanth 200
• Active Ingredient: Trenbolone Enanthate
• Lot Number: GP147H
• ISN Number: U7E3425A3353
• Expiration Date: September 2018
• Delivery Method: Injectable (10-milliliter multidose vial)
• Specification: 200 mg/ml trenbolone enanthate

Sample Acquisition and Testing

• Date Purchased: Between January 1, 2016, and March 15, 2016
• Source: European-based internet supplier
• Product Submitted By: AnabolicLab
• Analysis Paid For By: AnabolicLab
• Analysis Performed By: SIMEC AG
• Date Received by Lab: April 1, 2016
• Date Report Completed: April 14, 2016

Testing Results

Quantitative Dosage Testing (HPLC-UV):

• Claimed Dosage: 200 mg/ml trenbolone enanthate
• Measured Dosage: 229.3 mg/ml trenbolone enanthate
• Accuracy: 114.7% of the labeled claim
• Variance: +14.7% (measured dosage above the label claim by 14.7%)

Report Number: #GP147H-2016

Conclusion

The analysis of Geneza Pharmaceuticals GP Tren Enanth 200 determined a measured concentration of 229.3 mg/ml trenbolone enanthate, exceeding the label claim by 14.7%. This significant overdosage highlights inconsistencies in manufacturing but does not compromise the sterility of the product. The ISN number confirmed the product’s authenticity.

Commitment to Harm Reduction

AnabolicLab’s initiative aims to provide accurate, unbiased information through independent testing, ensuring consumers have reliable data to make informed decisions. These efforts help promote transparency and accountability in the anabolic steroid marketplace.

Disclaimer
The information provided here is for educational and harm reduction purposes only. AnabolicLab does not endorse or promote the use of anabolic steroids or other controlled substances.

Discuss the Geneza Pharmaceuticals GP Tren Enanth 200 lab test results on the AnabolicLab Forum.

(The following images are photographs of the actual product that was submitted for testing.)

Geneza Pharma GP Tren Enanth 200 Dosage Quantification Lab Results [PDF]
Does Geneza Pharma GP Tren Enanth 200 contain 200 milligram of trenbolone enanthate per milliliter? HPLC-UV (April 14, 2016) …

Size	680.93 KB
Downloaded	975 times
Last Updated	April 27, 2016
Download

---